Golgin A8: A Potential Drug Target in Cell Signaling (G390535)

Target Name: GOLGA8EP

NCBI ID: G390535

GOLGA8EP

Other Name(s): Golgin A8 family member E, pseudogene | golgin A8 family member E, pseudogene | GOLGA8E

Golgin A8: A Potential Drug Target in Cell Signaling

The Golgi system is a network of membrane-bound organelles that play a crucial role in the cell division process. It is composed of several families of transmembrane proteins, including the Golgin A8 family. Golgin A8 is a member of the Golgi A8 family and is involved in the assembly and disassembly of microtubules. It has also been shown to play a role in the regulation of cell signaling pathways and is a potential drug target.

Golgin A8 is a protein that consists of 184 amino acids. It has a unique structure, with a long extracellular region that is involved in its function. The extracellular region of Golgin A8 contains a series of conserved domains, including a leucine-rich repeat ( LRR), a calbindin domain, and a glycine-rich repeat (GGR). The LRR and GGR domains are known for their ability to interact with other proteins, while the calbindin domain is involved in the regulation of cell signaling pathways.

Golgin A8 has been shown to play a role in the regulation of several signaling pathways, including the TGF-β pathway and the Wnt pathway. TGF-β is a cytokine that plays a role in cell growth, differentiation, and survival. It is involved in the regulation of cell proliferation and has been implicated in the development of many diseases, including cancer. Golgin A8 has been shown to be involved in the regulation of TGF-β signaling by interacting with the transcription factor, TF-尾1.

In addition to its role in TGF-β signaling, Golgin A8 has also been shown to be involved in the regulation of the Wnt pathway. Wnt is a cytokine that plays a role in cell-cell signaling and has been implicated in the development of many diseases, including cancer. Golgin A8 has been shown to be involved in the regulation of Wnt signaling by interacting with the transcription factor, Wnt1.

Golgin A8 has also been shown to play a role in the regulation of cell signaling pathways that are not related to TGF-β or Wnt signaling. For example, it has been shown to be involved in the regulation of the production of extracellular vesicles (EVs ), which are small structures that are released from the cell surface and play a role in cell-cell signaling. EVs have been shown to play a role in the development of many diseases, including cancer. Golgin A8 has been shown to be involved in the regulation of EV production by interacting with the protein, EVT1.

Golgin A8 has also been shown to play a role in the regulation of the actinin cytoskeleton. Actinin is a protein that is involved in the regulation of cell movement and is composed of a series of microtubules. Golgin A8 has been shown to be involved in the Regulation of actinin cytoskeleton by interacting with the protein, A-tetratide synthase (ATS).

In conclusion, Golgin A8 is a protein that is involved in several signaling pathways and has been shown to play a role in the regulation of cell signaling pathways. Its unique structure, including the LRR, GGR, and calbindin domains, as well as its ability to interact with other proteins, make it a potential drug target. Further research is needed to fully understand the role of Golgin A8 in the regulation of cell signaling pathways and its potential as a drug target.

Protein Name: Golgin A8 Family Member E, Pseudogene

The "GOLGA8EP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GOLGA8EP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets